H2APEX Group (H2A) Fair Value & Analysis

Basic Materials · DE · Market cap €40.0M

Below-average quality, and screening another 16% overvalued on our models.

What matters now

• Weak quality (12/100) and above fair value at the same time, the margin of safety is missing on both counts.
• The model range is unusually wide (€0.3116 to €1.20). The outcome hinges heavily on assumptions, so read the point estimate with caution.
• Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range €0.7340 – €7.05 · fair‑value band €0.3116 – €1.20 · the €0.8260 price screens above the €0.6970 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

H2APEX Group (H2A) currently trades at €0.8260, while our model-based Fair Value estimate is €0.6970, implying the stock looks roughly 15.6% overvalued today. The Quality Score stands at 12/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at €11.1M. Revenue grew 70.4% year over year. Net debt stands at €33.5M. Fundamentals as of Jul 16, 2026

Our scenario range runs from €0.3116 (bear case) to €1.20 (bull case); at €0.8260, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 70% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -16%, H2A screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Dividend Discount (€7.75) versus Asset-Based (€0.3600). Highest evidence: Gordon GGM (70).

Key figures & financial health

Quality Score breakdown

About the company

H2APEX Group SCA develops, manufactures, and operates green hydrogen plants for the de-carbonization of industry and infrastructure in Germany and Luxembourg. It operates through Operations, Project Development, and Storage segments.

Full company description

H2APEX Group SCA develops, manufactures, and operates green hydrogen plants for the de-carbonization of industry and infrastructure in Germany and Luxembourg. It operates through Operations, Project Development, and Storage segments. The Operations segment includes production and selling of green hydrogen, as well as the derivatives electricity and heat generation. The Project Development segment comprises work related to project development and system integration for third-party hydrogen plants, as well as turnkey solutions for the supply of hydrogen are modular, tech-agnostic, and tailor-made. The Storage segment includes development and manufacturing of different hydrogen storage systems. It serves transportation and logistics, industry, engineering office, research, government, and automobile manufacturer sectors. H2APEX Group SCA was founded in 2000 and is headquartered in Rostock, Germany.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

H2APEX Group reported revenue of €10.0M in FY2025 versus €1.3M in FY2021, a compound +67.0%/yr. Reported net income was −€33.8M in FY2025.

H2A screens 16% overvalued. Compare with Linde plc →

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Explore undervalued stocks

More undervalued Basic Materials stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.